Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 45th San Antonio Breast Cancer Symposium will host 10,000 clinicians and scientists from all over the world and is the largest and most prestigious scientific gathering on breast cancer research. This international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of breast cancer. VJOncology will be in attendance to help disseminate the latest learnings from the meeting.
View all videos

SABCS 2022

San Antonio Breast Cancer Symposium 2022
06–10 December 2022 | San Antonio, TX

🎥@elisabettasabet of @IEOufficiale discusses the Phase III PREcoopERA trial on giredestrant in premenopausal ER+/HER2- #breastcancer:

➡️https://ow.ly/rOye50RJWy9⬅️

@myESMO #ESMOBreast24

May is #SkinCancerAwarenessMonth 📣

According to The American Cancer Society an estimated 100,640 new #melanomas will be diagnosed in the USA in 2024 🇺🇸

Check out our skin cancer channel for the latest news and updates 👉 https://www.vjoncology.com/subject/skin-cancer

📢We’re so excited! Only two weeks to go until #ASCO24!

From May 31st we’ll be interviewing #Oncology experts – to discover the latest in cancer treatment innovations head to ➡️http://VJOncology.com⬅️

@ASCO @VJOncology

#ESMOBreast24 | We had the pleasure to speak to @FioriPoulakaki, who discusses QoL issues after axillary treatment in #breastcancer.

Watch out for her interview and our latest podcast episode on our congress highlights at http://VJOncology.com🎙️

@myESMO #bcsm @Oncoalert

Load More

SABCS 2022

San Antonio Breast Cancer Symposium 2022
06–10 December 2022 | San Antonio, TX
The 45th San Antonio Breast Cancer Symposium will host 10,000 clinicians and scientists from all over the world and is the largest and most prestigious scientific gathering on breast cancer research. This international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of breast cancer. VJOncology will be in attendance to help disseminate the latest learnings from the meeting.
View all videos

🎥@elisabettasabet of @IEOufficiale discusses the Phase III PREcoopERA trial on giredestrant in premenopausal ER+/HER2- #breastcancer:

➡️https://ow.ly/rOye50RJWy9⬅️

@myESMO #ESMOBreast24

May is #SkinCancerAwarenessMonth 📣

According to The American Cancer Society an estimated 100,640 new #melanomas will be diagnosed in the USA in 2024 🇺🇸

Check out our skin cancer channel for the latest news and updates 👉 https://www.vjoncology.com/subject/skin-cancer

📢We’re so excited! Only two weeks to go until #ASCO24!

From May 31st we’ll be interviewing #Oncology experts – to discover the latest in cancer treatment innovations head to ➡️http://VJOncology.com⬅️

@ASCO @VJOncology

#ESMOBreast24 | We had the pleasure to speak to @FioriPoulakaki, who discusses QoL issues after axillary treatment in #breastcancer.

Watch out for her interview and our latest podcast episode on our congress highlights at http://VJOncology.com🎙️

@myESMO #bcsm @Oncoalert

Load More